Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions

Expert Opinion | By Carlyn Tan, MD; Crystal Denlinger, MD

Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site Results From the EXCEL Trial

Clinical Trial | By AH Gershlick, DE Kandzari, GW Stone et al.

Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting

Clinical Trial | By S Cho, TS Kang, J-S Kim et al.

Complex PCI procedures: challenges for the interventional cardiologist

Review Article | By Werner N, Nickenig G, Sinning JM.

Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention

Original Research | By Waldo SW, Secemsky EA, Yeh RW et al.

Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period

Original Research | By Landes U, Bental T, Levi A et al.

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Original Research | By Mohr FW, Morice MC, Kappetein AP et al.

Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation

Clinical Trial | By Tonino PA, Fearon WF, De Bruyne B et al.

Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

Original Research | By Behan MW, Holm NR, de Belder AJ et al.

Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease

Original Research | By J Sjaarda, H Gerstein, M Chong et al.